NEW YORK — Ré Vive has found a new growth factor — literally. The high-end treatment brand, whose claim to fame stems from the Nobel Prize-winning discovery of Epidermal Growth Factor, or EGF, has added a new ingredient to its mix, called Insulin-like Growth Factor, or IGF.

Until recently, Louisville, Ky.-based plastic surgeon Dr. Gregory Bays Brown, who launched Ré Vive in 1997, relied solely on EGF as the line’s key ingredient. Discovered in 1960 by biochemists Stanley Cohen and Rita Monpalchini, the human protein chain was found to stimulate cell production in the epidermis — a finding that made the two researchers joint Nobel laureates for medicine and physiology in 1986.

To Read the Full Article

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus